Form 4: Arteris Inc. COO Sells Shares Under 10b5-1 Trading Plan

Arteris Inc.'s Chief Operating Officer, Laurent R. Moll, sold 1,161 shares of common stock at $12.52 per share on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Laurent R. Moll, the Chief Operating Officer of Arteris, Inc., executed a sale of company stock.
• The transaction involved the sale of 1,161 shares of common stock.
• The sale price was $12.52 per share.
• The transaction occurred on January 6, 2025.
• This sale was conducted under a pre-existing 10b5-1 trading plan adopted on March 15, 2024.
• Following the transaction, Moll directly owns 450,600 shares of Arteris, Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of an insider stock sale under a pre-arranged trading plan, which is neither positive nor negative.

Industry Context

This is a routine disclosure of an insider stock sale under a pre-arranged trading plan, which is a common practice among corporate executives.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a standard practice for corporate insiders to avoid accusations of trading on non-public information.
• The sale of 1,161 shares is a relatively small transaction compared to the total shares owned by the COO, which is 450,600 shares.
• Similar transactions are regularly reported by executives at other publicly traded companies.

Stakeholder Impact

• The sale of shares by a company executive may have a minor impact on investor sentiment, but is unlikely to significantly affect the share price given the pre-arranged nature of the transaction.

Key Dates

Keywords

Arteris Inc., Laurent R. Moll, insider trading, 10b5-1 plan, stock sale, chief operating officer, AIP